gene therapy - search results

It is estimated that ten percent of the costs of health care in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) being associated with lost work is related to injury or dysfunction of the musculoskeletal system Surgical and subsequent rehabilitative interventions are an important part...

Associate Professor of Medical Genetics, Silvia Deaglio, highlights the research strides being made in the fight against chronic lymphocytic leukemia

Manuela Côrte-Real outlines how yeast can clarify the regulation of cell death pathways and provide new therapeutic strategies for human diseases

The European Federation of Pharmaceutical Industries and Associations (EFPIA) explain how SAFE-T DIKI is advancing research into drug-induced kidney injury

Uterine fibroids represent a prevalent benign gynaecologic problem in the U.S, here Romana A. Nowak of the University of Illinois explains

The human genome is composed of over 3 billion letters, here Dr Yuval Ebenstein, Principal Investigator, Tel Aviv University sheds light on it.

Canadian Cancer Society’s Dr Rob Nuttall and Shawn Chirrey explain how fighting against breast cancer requires ongoing support for research and screening

Prof Colin J Suckling, University of Strathclyde's Department of Pure & Applied Chemistry, discusses heterocyclic chemistry.

Dr. Lisa Halvorson, U.S. National Institutes of Health discusses the importance of gynaecologic research to develop new treatments and keep women healthy

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

Professor Martin Flück and colleagues at Balgrist University Hospital's Laboratory for Muscle Plasticity investigate possible therapies for weak muscles It is estimated that 10% of the costs of healthcare in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) associated with lost work are related to injury or...

By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

Better understanding of the factors at play will enable efforts to reduce HIV transmission in Southern and Eastern Africa, where incidence rates are highest The global HIV epidemic peaked at 3 million new infections in the year 2000. However, since 2010 the decline has stalled at 2 million new infections...

Low vision can be a blight on the lives of those it affects, which is why it’s a National Eye Institute priority, as Dr Cheri Wiggs told Open Access Government Around 4.2 million people in America are visually impaired, which is expected to increase to 7.2 million in 2030. Of...

The Orkdal model of cancer care rests on collaboration between specialist oncology and community care in palliative treatment, as Anne Kari Knudsen explains The Norwegian Orkdal model of cancer care has been called “the future of cancer care”. The aim is to develop and implement a model for optimal cancer...

Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, stresses the need for prevention and spotlights joint efforts to tackle rare forms of cancer The EU vs. cancer battle has been underway for 32 years – more than half of my lifetime. Since the Heads of State of the European...

Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...

Ahead of World AIDS Day on 1 December, the World Health Organization has released new guidelines on HIV self-testing to improve access to HIV diagnosis According to a WHO progress report published this week, lack of diagnosis for HIV is one of the major obstacles that stands in the way...

Jo Vandesompele, Chief Scientific Officer at Biogazelle, outlines how non-coding RNA research for cancer can help develop a more targeted treatment approach  DNA is the hereditary code that is passed on from parents to their children. Every cell inside our body has the same code that contains the blueprint of...